Literature DB >> 17409840

Significance of the number of positive lymph nodes in resected non-small cell lung cancer.

Takayuki Fukui1, Shoichi Mori, Kohei Yokoi, Tetsuya Mitsudomi.   

Abstract

BACKGROUND: In the current tumor, node, metastasis (TNM) classification of lung cancer, N status is defined by the anatomic extent of lymph node metastases. In this study, we evaluated the prognostic significance of the number of positive lymph nodes in resected non-small cell lung cancer.
METHODS: We retrospectively studied 289 patients with non-small cell lung cancer who underwent surgery, and we compared the prognostic significance of the number of positive nodes with the pN number by using multivariate analysis. Patients were classified into four groups according to the number of positive nodes: those without nodal metastasis were n, those with one to three positive nodes were n, those with four to six were n, and those with more than seven were n.
RESULTS: The 5-year survival rate was 77% in the n patients, 58% in n, 42% in n, and 6% in n, which indicates that an increased number of positive lymph nodes was associated with poor prognosis. Among the pN2 patients, the n group had a better survival rate than the n and n groups. Multivariate analysis showed that the number of positive nodes was a significant prognostic factor, equal to the currently used pN number. Hazard ratios for pN1 and pN2 with respect to pN0 were 2.13 and 3.49; and 2.07, 3.03, and 10.4 for n, n, and n with respect to n. In addition, we found that our classification could reflect the better prognoses of skip or single-station nodal metastases.
CONCLUSION: The number of positive lymph nodes is a strong independent prognostic factor in non-small cell lung cancer and may add new information to the pN categories of the current TNM classification.

Entities:  

Mesh:

Year:  2006        PMID: 17409840

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  43 in total

1.  Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Authors:  Chang-Li Wang; Yue Li; Dong-Sheng Yue; Lian-Min Zhang; Zhen-Fa Zhang; Bing-Sheng Sun
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes.

Authors:  Haruhisa Matsuguma; Izumi Oki; Rie Nakahara; Norihisa Ohata; Seiji Igarashi; Kiyoshi Mori; Shunsuke Endo; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

3.  The impact of positive nodal chain ratio on individualized multimodality therapy in non-small-cell lung cancer.

Authors:  Qinchen Cao; Baozhong Zhang; Lujun Zhao; Changli Wang; Liqun Gong; Jun Wang; Qingsong Pang; Kai Li; Weishuai Liu; Xue Li; Peng Wang; Ping Wang
Journal:  Tumour Biol       Date:  2015-01-27

4.  Response to editorial titled 'Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissection'.

Authors:  Raymond U Osarogiagbon; Laura E Miller; Christopher G Wang; Robert A Ramirez
Journal:  Transl Lung Cancer Res       Date:  2013-04

Review 5.  Towards optimal pathologic staging of resectable non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Gail E Darling
Journal:  Transl Lung Cancer Res       Date:  2013-10

6.  Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinoma.

Authors:  Kotaro Nomura; Keiju Aokage; Tokiko Nakai; Shingo Sakashita; Tomohiro Miyoshi; Kenta Tane; Joji Samejima; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-02       Impact factor: 4.553

7.  The "N"-factor in non-small cell lung cancer: staging system and institutional reports.

Authors:  Ottavio Rena
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

8.  Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.

Authors:  Chukwumere E Nwogu; Adrienne Groman; Daniel Fahey; Sai Yendamuri; Elisabeth Dexter; Todd L Demmy; Austin Miller; Mary Reid
Journal:  Ann Thorac Surg       Date:  2012-03-20       Impact factor: 4.330

9.  Improving the pathologic evaluation of lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer.

Authors:  Fuqiang Dai; Lunxu Liu; Guowei Che; Nanbin Yu; Qiang Pu; Shangfu Zhang; Junliang Ma; Lin Ma; Zongbing You
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.